Financial statements Sanopharm
Balance sheet of Sanopharm
Company age:
Age:
7 y. 7 m. 16 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of SANOPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 347 892,08 | 570 854,23 | 738 991,63 | 1 906 074,25 | 2 851 646,15 | 2 842 831,99 |
| A. Fixed assets | 0,00 | 0,00 | 143 866,68 | 552 996,77 | 296 638,54 | 304 672,65 |
| B. Current assets | 347 892,08 | 570 854,23 | 595 124,95 | 1 353 077,48 | 2 555 007,61 | 2 538 159,34 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 347 892,08 | 570 854,23 | 738 991,63 | 1 906 074,25 | 2 851 646,15 | 2 842 831,99 |
| A. Equity | 61 890,25 | 338 913,49 | 367 899,32 | 1 591 246,81 | 2 376 371,07 | 2 642 005,63 |
| B. Liabilities and provisions for liabilities | 286 001,83 | 231 940,74 | 371 092,31 | 314 827,44 | 475 275,08 | 200 826,36 |
| I. Long-term liabilities | 183 224,66 | 192 224,66 | 179 188,33 | 93 786,30 | 97 786,30 | 109 786,30 |
| II. Short-term liabilities | 102 777,17 | 39 716,08 | 191 903,98 | 221 041,14 | 377 488,78 | 91 040,06 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.